These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


194 related items for PubMed ID: 9375876

  • 21. Vasculitis complicating granulocyte colony stimulating factor treatment of leukopenia and infection in Felty's syndrome.
    Farhey YD, Herman JH.
    J Rheumatol; 1995 Jun; 22(6):1179-82. PubMed ID: 7545756
    [Abstract] [Full Text] [Related]

  • 22. Prevention and control of infections in patients with severe congenital neutropenia; a follow up study.
    Salehi T, Fazlollahi MR, Maddah M, Nayebpour M, Tabatabaei Yazdi M, Alizadeh Z, Eshghi P, Chavoshzadeh Z, Movahedi M, Hamidieh AA, Cheraghi T, Pourpak Z, Moin M.
    Iran J Allergy Asthma Immunol; 2012 Mar; 11(1):51-6. PubMed ID: 22427476
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection.
    Heuft HG, Goudeva L, Pulver N, Grigull L, Schwella N, Blasczyk R.
    Transfusion; 2005 Apr; 45(4):604-12. PubMed ID: 15819683
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Moderate and severe neutropenia in patients with systemic lupus erythematosus.
    Martínez-Baños D, Crispín JC, Lazo-Langner A, Sánchez-Guerrero J.
    Rheumatology (Oxford); 2006 Aug; 45(8):994-8. PubMed ID: 16484291
    [Abstract] [Full Text] [Related]

  • 27. Failure of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in a patient with Kostmann syndrome.
    Hazar V, Ongun H, Yeşilipek MA, Yeğin O.
    Turk J Pediatr; 1999 Aug; 41(1):117-20. PubMed ID: 10770686
    [Abstract] [Full Text] [Related]

  • 28. Biological and clinical correlates after chemotherapy and granulocyte colony-stimulating factor administration.
    Higa GM, DeVore RF, Auber ML, Lynch JP, Landreth KS.
    Pharmacotherapy; 1998 Aug; 18(1):1-8. PubMed ID: 9469674
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Effects of granulocyte colony-stimulating factor in children with severe neutropenia.
    Welte K, Zeidler C, Reiter A, Riehm H.
    Acta Haematol Pol; 1994 Aug; 25(2 Suppl 1):155-62. PubMed ID: 7520659
    [Abstract] [Full Text] [Related]

  • 31. Beneficial effect of granulocyte-colony stimulating factor in scleromyxoedema associated with severe idiopathic neutropenia.
    Cohen AM, Hodak E, David M, Mittelman M, Gal R, Stern R.
    Br J Dermatol; 1996 Oct; 135(4):626-9. PubMed ID: 8915161
    [Abstract] [Full Text] [Related]

  • 32. The effect of granulocyte colony stimulating factor on neutrophil functions in children with neutropenia after chemotherapy in the course of neoplasma.
    Czygier M, Dakowicz Ł, Szmitkowski M.
    Adv Med Sci; 2007 Oct; 52():143-6. PubMed ID: 18217407
    [Abstract] [Full Text] [Related]

  • 33. [Granulocyte colony-stimulating factor in the newborn neutropenic patient].
    Castillo Salinas F, Díaz de Heredia Rubio C, Salcedo Abizanda S, Ferrer Comalat A, Bastida Vila P, Ortega Aramburu JJ, Peguero Monforte G.
    An Esp Pediatr; 1998 Dec; 49(6):615-8. PubMed ID: 9972625
    [Abstract] [Full Text] [Related]

  • 34. Effects of human granulocyte colony-stimulating factor in a patient with idiopathic neutropenia.
    Jakubowski AA, Souza L, Kelly F, Fain K, Budman D, Clarkson B, Bonilla MA, Moore MA, Gabrilove J.
    N Engl J Med; 1989 Jan 05; 320(1):38-42. PubMed ID: 2462670
    [No Abstract] [Full Text] [Related]

  • 35. Leukocytoclastic vasculitis in patients with severe congenital neutropenia.
    Kilic SS, Mustafayeva S, Ipek K, Adim SB.
    J Trop Pediatr; 2010 Oct 05; 56(5):359-62. PubMed ID: 20100783
    [Abstract] [Full Text] [Related]

  • 36. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects.
    Akizuki S, Mizorogi F, Inoue T, Sudo K, Ohnishi A.
    Bone Marrow Transplant; 2000 Nov 05; 26(9):939-46. PubMed ID: 11100272
    [Abstract] [Full Text] [Related]

  • 37. Low Fcgamma receptor III and high granulocyte colony-stimulating factor serum levels correlate with the risk of infection in neutropenia due to Felty's syndrome or systemic lupus erythematosus.
    Hellmich B, Csernok E, de Haas M, von dem Borne AE, Schatz H, Gross WL, Schnabel A.
    Am J Med; 2002 Aug 01; 113(2):134-9. PubMed ID: 12133752
    [Abstract] [Full Text] [Related]

  • 38. Cutaneous manifestations of granulocyte colony-stimulating factor.
    White JM, Mufti GJ, Salisbury JR, du Vivier AW.
    Clin Exp Dermatol; 2006 Mar 01; 31(2):206-7. PubMed ID: 16487091
    [Abstract] [Full Text] [Related]

  • 39. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O, Foss B, Petersen H.
    Eur Cytokine Netw; 2001 Mar 01; 12(2):231-8. PubMed ID: 11399510
    [Abstract] [Full Text] [Related]

  • 40. [G-CSF therapy in a neonate with alloimmune neutropenia].
    Kümmerle-Deschner J, Scheel-Walter HG, Speer CP.
    Z Geburtshilfe Neonatol; 1997 Mar 01; 201(6):273-6. PubMed ID: 9491549
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 10.